This patent covers a tissue culture media useful for the expansion of CD34+ hematopoietic stem cells that does not require the use of serum, and thus is easier for clinical implimentation. The patent is owned by Invitrogen which sells various laboratory and tissue culture reagents.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.